The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas.
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,004
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S. J., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 973
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
Felker, G. M., Allen, L. A., Pocock, S. J., Shaw, L. K., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.067 · Cited by 947
Tonelli, M., Sacks, F., Arnold, M., Moye, L., Davis, B., & Pfeffer, M. (2008) · Circulation · doi:10.1161/circulationaha.107.727545 · Cited by 816
Red blood cell distribution width and the risk of death in middle-aged and older adults
Patel, K. V., Ferrucci, L., Ershler, W. B., Longo, D. L., & Guralnik, J. M. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.11 · Cited by 618
Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort
Perlstein, T. S., Weuve, J., Pfeffer, M. A., & Beckman, J. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.55 · Cited by 533
Prognosis of Pulmonary Arterial Hypertension*
McLaughlin, V. V., Presberg, K. W., Doyle, R. L., Abman, S. H., McCrory, D. C., Fortin, T., & Ahearn, G. (2004) · Chest · doi:10.1378/chest.126.1_suppl.78s · Cited by 511
A USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Self-citation
Cited by
Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension
Rhodes, C. J., Howard, L. S., Busbridge, M., Ashby, D., Kondili, E., Gibbs, J. S. R., Wharton, J., & Wilkins, M. R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.057 · Cited by 266
Metadata
- Authors
- Hampole, C. V., Mehrotra, A. K., Thenappan, T., Gomberg-Maitland, M., & Shah, S. J.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 104
- Issue
- 6
- Pages
- 868-872
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W1998740550
- Cited by
- 254
- References
- 15
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas. https://app.cochat.ai/papers/10.1016/j.amjcard.2009.05.016
- The paper
- Hampole, C. V., Mehrotra, A. K., Thenappan, T., Gomberg-Maitland, M., & Shah, S. J. (2009). Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas. The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2009.05.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.